In pancreatic cancer, evidence exists for changes toward a typical pro-inflammatory cytokine expression: in tissues higher MIF, IL-8, and CXCR-4 expression and reduced HLA-DR expression, and in serum higher IL-6 and IL-10 levels. This evidence concerns the gene CXCL8 and familial pancreatic carcinoma.